

Fundamental dimension Equity attribute | HOODLeader $95.56▼-1.06% Cap $75.55BP/E 41.4x QuantScore53/100 | 039490.KSPeer —— Cap —P/E — QuantScore— | BLSHPeer $28.21▼-3.36% Cap $4.28BP/E -3.1x QuantScore47/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical Trend, RSI, MACD & signal consensus | |||
47/100 |
— |
33/100 |
Valuation Multiples, PEG & DCF upside | 8/100 | — | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 32/100 | — | 65/100 |
Growth Revenue / earnings growth & margins | 88/100 | — | 21/100 |
Sentiment Analyst ratings, targets & revisions | 91/100 | — | 83/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 41.4x | — | -3.1x |
Forward P/E (next FY) | 43.3x | — | 62.6x |
EV / EBITDA (TTM) | 39.3x | — | -4.3x |
Price / Sales | 15.3x | — | 0.0x |
Price / Free Cash Flow | 424.5x | — | 44.1x |
PEG ratio | 3.00 | — | 0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | — | 4 / 9 |
Altman Z-Score | 1.37 (Distress) | — | 53.68 (Safe) |
Total debt / equity | 2.40 | — | 0.21 |
Quick ratio | 1.2x | — | 22.4x |
Interest coverage | 41.3x | — | -0.1x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +51.6% | — | -2.1% |
Net income growth YoY | +33.5% | — | -1073.8% |
Gross margin (TTM) | 81.5% | — | 0.0% |
Operating margin (FY) | 46.8% | — | 0.0% |
FCF margin (FY) | 35.4% | — | -0.0% |
5. Trailing price performancePrice change over period |
1M return | -21.3% | — | -28.9% |
3M return | +0.2% | — | +17.7% |
6M return | +12.2% | — | -29.4% |
Year to date | -15.9% | — | -25.5% |
1Y return | -32.0% | — | -48.0% |
3Y return | +920.1% | — | -58.5% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-40.35 -142.2% premium | — — | $-131,275.24 -465450.0% premium |
Wall Street consensus target | $138.60 +45.0% · range $110.00–$170.00 | — — | $44.00 +56.0% · range $30.00–$61.00 |
Consensus stance | 74% Buy19% Hold7% Sell | — | 60% Buy40% Hold0% Sell |